Wen Jian-Ting, Xin Ling, Wan Lei, Fang Yan-Yan, Dong Wen-Zhe, Liu Jian
Anhui University of Chinese Medicine Hefei 230038,China.
the First Affliated Hospital of Anhui University of Chinese Medicine Hefei 230031,China.
Zhongguo Zhong Yao Za Zhi. 2019 Mar;44(5):1053-1057. doi: 10.19540/j.cnki.cjcmm.20181205.002.
To evaluate the effect of traditional Chinese medicine(TCM) invigorating spleen unit therapy on inflammatory markers of osteoarthritis(OA) patients by random walk model. The patient information was collected by the data processing system of medical records of the First Affiliated Hospital of Anhui University of Traditional Chinese Medicine. In-patient information of the department of rheumatology of the hospital between June 2012 and December 2016 was collected and summarized. Based on the use of traditional Chinese medicine decoction and hospital-prepared compound Qiyi Capsules(Xinfeng Capsules),the patients were divided into the unit therapy group and the simple endotherapy group. The random walk model was used to evaluate the effect of traditional Chinese medicine invigorating spleen unit therapy on TCM spleen therapy unit(ESR) and high sensitive C reactive protein(hs-CRP). A total of 3 517 cases of OA patients met the study requirements. The simple endotherapy group had 1 771 cases(50. 36%),while the unit therapy group had 1 746 cases(49. 64%). The baseline data analysis showed that the general information of the cases,the TCM oral intake frequency and the core prescription information had no statistically significant difference,with comparability. The unit therapy group showed the maximum ESR stochastic volatility at 924,walking step number of 1 771,forward walking growth rate at 0. 264 5,ratio at3. 78,random fluctuation power law at 0. 306 5± 0. 076 8,positive increase rate of comprehensive evaluation index at 0. 264 5,and comprehensive evaluation index record number of 1 771; whereas the simple endotherapy group showed the maximum ESR random fluctuation value at 478,walking step number of 1 399,forward walking growth rate at 0. 152 4,ratio at 6. 56,random fluctuation power law at 0. 347 4±0. 101 7,positive increase rate of comprehensive evaluation index at 0. 152 4,and comprehensive evaluation index record number of 1 399. The unit therapy group showed the maximum hs-CRP random fluctuation value at 391,walking step number of1 081,forward walking growth rate at 0. 178 1,ratio at 5. 62,random fluctuation power law at 0. 343 6±0. 094 7,positive increase rate of comprehensive evaluation index at 0. 178 1,and comprehensive evaluation index record number of 1 081; while the simple endotherapy groups showed the maximum hs-CRP random fluctuation value at 210,walking step number of 797,forward walking growth rate at0. 113 2,ratio at 8. 83,random fluctuation power law at 0. 382 6±0. 109,positive increase rate of comprehensive evaluation index at0. 113 2,and comprehensive evaluation index record number of 797. According to our department of rheumatism,there was a longrange correlation between the two groups in the comprehensive evaluation index and the intervention measures. TCM spleen strengthening unit therapy has a better effect in alleviating the inflammatory index of OA than traditional Chinese medicine.
采用随机游走模型评估中医健脾单元疗法对骨关节炎(OA)患者炎症指标的影响。患者信息通过安徽中医药大学第一附属医院病案数据处理系统收集。收集并汇总2012年6月至2016年12月期间该院风湿科住院患者信息。依据使用中药汤剂及院内制剂复方芪一胶囊(新风胶囊)情况,将患者分为单元疗法组和单纯内服疗法组。运用随机游走模型评估中医健脾单元疗法对中医脾疗法单元(ESR)及高敏C反应蛋白(hs-CRP)的影响。共3517例OA患者符合研究要求。单纯内服疗法组1771例(50.36%),单元疗法组1746例(49.64%)。基线数据分析显示,病例的一般信息、中医服药频次及核心处方信息差异无统计学意义,具有可比性。单元疗法组ESR随机波动最大值为924,步数为1771,向前行走增长率为0.2645,比值为3.78,随机波动幂律为0.3065±0.0768,综合评价指标正向增长率为0.2645,综合评价指标记录数为1771;而单纯内服疗法组ESR随机波动最大值为478,步数为1399,向前行走增长率为0.1524,比值为6.56,随机波动幂律为0.3474±0.1017,综合评价指标正向增长率为0.1524,综合评价指标记录数为1399。单元疗法组hs-CRP随机波动最大值为391,步数为1081,向前行走增长率为0.1781,比值为5.62,随机波动幂律为0.3436±0.0947,综合评价指标正向增长率为0.1781,综合评价指标记录数为1081;单纯内服疗法组hs-CRP随机波动最大值为210,步数为797,向前行走增长率为0.1132,比值为8.83,随机波动幂律为0.3826±0.109,综合评价指标正向增长率为0.1132,综合评价指标记录数为797。据我科观察,两组综合评价指标与干预措施之间存在长程相关性。中医健脾单元疗法在缓解OA炎症指标方面较单纯中药疗法效果更佳。
Zhong Xi Yi Jie He Xue Bao. 2008-9
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2021-4-20
Evid Based Complement Alternat Med. 2021-11-22
Cochrane Database Syst Rev. 2012-5-16
Nan Fang Yi Ke Da Xue Xue Bao. 2021-4-20